Page last updated: 2024-10-29

ioxaglate and Cancer of Liver

ioxaglate has been researched along with Cancer of Liver in 1 studies

Ioxaglic Acid: A low-osmolar, ionic contrast medium used in various radiographic procedures.
ioxaglic acid : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an acetyl(methyl)amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"Measurement of serum pancreastatin levels is an easy and useful method to predict success in patients who undergo HACE plus somatostatin therapy for metastatic neuroendocrine tumors to the liver."7.71Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. ( Desai, DC; Jung, SS; Khabiri, H; Martin, EW; O'Dorisio, TM; Schirmer, WJ; Villanueva, V, 2001)
"Measurement of serum pancreastatin levels is an easy and useful method to predict success in patients who undergo HACE plus somatostatin therapy for metastatic neuroendocrine tumors to the liver."3.71Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. ( Desai, DC; Jung, SS; Khabiri, H; Martin, EW; O'Dorisio, TM; Schirmer, WJ; Villanueva, V, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desai, DC1
O'Dorisio, TM1
Schirmer, WJ1
Jung, SS1
Khabiri, H1
Villanueva, V1
Martin, EW1

Other Studies

1 other study available for ioxaglate and Cancer of Liver

ArticleYear
Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors.
    Regulatory peptides, 2001, Jan-12, Volume: 96, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Chemoembolization, Therape

2001